Lehninger Principles of Biochemistry: Fourth Edition
Lehninger Principles of Biochemistry: Fourth Edition
Lehninger Principles of Biochemistry: Fourth Edition
Cox
(1) Irreversible Inhibition: inhibitor binds tightly, often covalently, to the enzyme, permanently inactivating it.
In the presence of a competitive inhibitor, I, Vmax [S] v0 = Km(1 + [I]/Ki) + [S] [E][I] where Ki (inhibition constant) = [EI] Then, Vmax [S] v0 = Km+ [S]
where = (1 + [I]/Ki) The type of inhibition can be determined using the double reciprocal plot.
COO CH2 CH2 COO Succinate COO CH2 COO Malonate succinate dehydrogenase succinate dehydrogenase
OOC
COO
Fumarate
No reaction
An uncompetitive inhibitor binds at a site other than the active site and, binds only to the ES complex.
Since I does not share the binding site with S, uncompetitive inhibition cannot be overcome by high [S].
Vmax,app decrease (by a factor of -1) Km,app decrease (by a factor of -1)
Ex) Compulsory ordered Bi-Bi reaction. B BX E + AX EAX EAXB EABX EA E + A EAXBI No reaction
Inhibitor binds at a site other than the active site (E or ES) and causes changes in the overall 3-D shape of the enzyme that leads to a decrease in activity:
v0 =
Vmax[S] Km + [S]
Hydrophobic pocket
Lehninger p.216
[7] Enzyme regulation The rates of enzyme-catalyzed reactions are altered by activators and inhibitors (a.k.a. effector molecules). (1) Allosteric enzymes: have more than one site, where effector binding at one site induces a conformational change in the enzyme, altering its affinity for a substrate. An allosteric activator increases enzyme rate of activity, an allosteric inhibitor decreases its activity.
Regulation mechanism: Reversible, noncovalent binding of allosteric effectors. Covalent modification (phosphorylation, adenylation, etc.). Binding by separate regulatory proteins. Proteolytic activation (irreversible).
In most cases, the first enzyme of the multireaction pathway (catabolism, anabolism) is a regulatory enzyme to avoid unneeded accumulation of the intermediates.
(2) Feedback inhibition: An enzyme, early in the metabolic pathway, is inhibited by an end-product. Often takes place at the committed step of the pathway, the step which commits a metabolite to a pathway.
(3) Regulatory enzymes are generally more complex than other enzymes, i.e. Aspartate transcarbamoylase first step in CTP synthesis, converts Asp to N-carbamoyl Asp CO2 + Gln + ATP H2N-(C=O)-OPO32(carbamoyl phosphate) Asp transcarbamoylase catalyzes the following reaction: Carbamoyl phosphate + Asp N-carbamoylAspartate CTP (building block of DNA) CTP, the end product of the reaction, decreases the rate of enzyme activity allosteric inhibitor. ATP increases the rate of enzyme activity allosteric activator. Many effectors work in concert to regulate the pathway.
Catalytic domains
Regulatory domains
(a) Homotropic allosteric enzymes (substrate = effector): - Multisubunit enzymes. - The same binding site on each subunit functions as both active site and regulatory site. - Substrate acts as an activator as well. (O2 and Hb). - Binding of one substrate alters the enzymes conformation and enhances the binding of subsequent substrates. Sigmoidal kinetics. sensitive to a small change in [S].
(b) Heterotropic allosteric enzymes (substrate = effector)
(5) Reversible Covalent Modification: is the making and breaking of a covalent bond between a non-protein group and an enzyme that affects its activity.
Examples of some transfer groups: Phosphate groups: cause a change in the 3D structure enhancing or inhibiting enzyme activity. Enzymes are phosphorylated by a protein kinase or dephosphorylated by a phosphatase.
Adenylation: the transfer of adenylate from ATP ADP-ribosylation: the transfer of an adenosine diphosphateribosyl moiety from NAD+ Uridylation Methylation
(6) Proteolytic activation: Some enzymes are synthesized as larger inactive precursor forms called proenzymes or zymogens. Activation involves the irreversible hydrolysis of one or more peptide bonds, resulting in an active form.